Mantle cell lymphoma trials in Netherlands

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Not yet taking people in Netherlands
  Addition of ritonavir to ibrutinib treatment in patients with chronic leukemia and certain types of lymphoma

  Where

  Almelo, Amersfoort, Amstelveen, Amsterdam, Apeldoorn, Breda, Doetichem, Emmen, Goes, Gouda, Groningen, Hoofddorp, Hoorn Nh, Leeuwarden, Nieuwegein, Rotterdam, 's-Gravenhage, 'S-Hertogenbosch, Tilburg, Venlo, Zaandam, Zwolle

  Age

  18 years and over

  People

  177

  Run by

  Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

  See details and how to join2026-526101-15-00 · EU 2026-526101-15-00
• Phase 1Taking people
  A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  Where

  Groningen, Nijmegen, Rotterdam, Utrecht

  Age

  18 years and over

  People

  572 worldwide

  Run by

  Nurix Therapeutics, Inc.

  See details and how to joinNCT05131022 · EU 2023-510541-25-00
• Phase 2Taking people
  CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma

  Where

  Amsterdam, Groningen, Rotterdam

  Age

  18 years to 75 years

  People

  150 worldwide

  Run by

  Christian Schmidt, MD

  See details and how to joinNCT06482684 · EU 2022-502405-15-01